Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (R35 – Clinical Trial Optional)

0
96

Opportunity ID: 322238
Opportunity Number: NOT-GM-19-061
Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (R35 – Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.859
Eligible Applicants: State governments
County governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: Nov 04, 2019
Last Updated Date: Nov 04, 2019
Estimated Synopsis Post Date: May 01, 2020
Fiscal Year: 2021
Award Ceiling: $250,000
Award Floor:
Estimated Total Program Funding:
Expected Number of Awards:
Description: The purpose of this Notice is to inform the biomedical research community that NIGMS is planning to issue a funding opportunity announcement (FOA) to continue the Maximizing Investigators’ Research Award for Early Stage Investigators (MIRA-ESI) (R35) program. The FOA is intended for new applications from early stage investigators. This Notice is being provided to allow potential applicants sufficient time to develop responsive projects. The FOA is expected to be published in Spring 2020 with an expected first application due date in October 2020. This FOA will utilize the R35 activity code. Details of the planned FOA are provided below.
Version: 1





Visit the Official Webpage For More Details on Notice of Intent to Publish a Funding Opportunity Announcement for Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (R35 – Clinical Trial Optional)